Botulinum toxin A (BTX-A) has emerged as an indispensable intervention for managing spasticity in children with cerebral palsy (CP). By inhibiting acetylcholine release at the neuromuscular junction, ...
Spastic cerebral palsy is a disorder that involves muscle stiffness. Symptoms and signs may include difficulty walking, trouble manipulating objects, and vision, hearing, or speech challenges.